Literature DB >> 15288262

Notch signaling in neuroblastoma.

Sven Påhlman1, Marie-Thérése Stockhausen, Erik Fredlund, Håkan Axelson.   

Abstract

Neuroblastoma is a pediatric tumor that originates from precursor cells of the sympathetic nervous system that have discontinued their normal differentiation program. This review is focused on involvement of the Notch signaling cascade in the process of differentiation in neuroblastoma cells and normal cells of the sympathetic nervous system. Hypoxia induces dedifferentiation of neuroblastoma cells in vivo and in vitro, and under oxygen-compromised conditions the Notch cascade is activated. This activation might promote development of the dedifferentiated phenotype. The implications of these observations for tumor biology are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288262     DOI: 10.1016/j.semcancer.2004.04.016

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  26 in total

1.  A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Authors:  K Zhang; P Wong; L Zhang; B Jacobs; E C Borden; J C Aster; B Bedogni
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

2.  Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.

Authors:  Hong Qiu; Patrick M Zmina; Alex Y Huang; David Askew; Barbara Bedogni
Journal:  Cancer Lett       Date:  2018-07-21       Impact factor: 8.679

3.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Authors:  Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

4.  The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo.

Authors:  Peng Xu; Mingzhe Qiu; Zhiyong Zhang; Chunsheng Kang; Rongcai Jiang; Zhifan Jia; Guangxiu Wang; Hao Jiang; Peiyu Pu
Journal:  J Neurooncol       Date:  2009-09-22       Impact factor: 4.130

5.  Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.

Authors:  Fredrik Hedborg; Reiner Fischer-Colbrie; Nurtena Ostlin; Bengt Sandstedt; Maxine G B Tran; Patrick H Maxwell
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

6.  Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity.

Authors:  Yuri Kim; Qun Lin; Daniel Zelterman; Zhong Yun
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 7.  NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia.

Authors:  P J Real; A A Ferrando
Journal:  Leukemia       Date:  2009-04-09       Impact factor: 11.528

Review 8.  Cancer stem cells and brain tumors.

Authors:  A Pérez Castillo; D Aguilar-Morante; J A Morales-García; J Dorado
Journal:  Clin Transl Oncol       Date:  2008-05       Impact factor: 3.405

9.  Notch1 is an effector of Akt and hypoxia in melanoma development.

Authors:  Barbara Bedogni; James A Warneke; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

Review 10.  Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.

Authors:  Margaret E Macy; Kelly K Sawczyn; Timothy P Garrington; Douglas K Graham; Lia Gore
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.